Las Vegas, NV -- (SBWIRE) -- 10/05/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Bristol-Myers Squibb Co (NYSE:BMY), Johnson & Johnson (NYSE:JNJ), Zoetis Inc (NYSE:ZTS), Mylan Inc (NASDAQ:MYL)
Bristol-Myers Squibb Co (NYSE:BMY) managed to keep its gain at 2.06% on below -normal volume of 6.27M shares. The stock settled at $47.52 after floating in a range of $46.33 to $47.55. Its latest price has reached market capitalization of $78.23 billion. Its 52-week range has been $30.64 to $49.57. Bristol-Myers Squibb Company, a biopharmaceutical company, discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products that help patients prevail over serious diseases worldwide.
For How Long BMY will fight for Profitability? Read This Trend Analysis report
Johnson & Johnson (NYSE:JNJ) traded up on a volume of 6.05 million, lower than its standard daily volume. Shares have gained 0.84% to $87.31. Over the last twelve months, the stock has gained 26.7% and faced a worst price of $67.80. Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the health care field worldwide.
For How Long JNJ’s Gloss will Attract Investors? Find out via this report
Zoetis Inc (NYSE:ZTS) settled 1.81% higher at $32.05 on above-normal volume of 5.80M shares during the last trading day. The stock has its 12-month high at $35.42 and 52-week low price was $28.81. It traded in a range of $31.64 to $32.56 during the last trading day. Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines and vaccines for livestock and companion animals in the United States, Europe, Africa, the Middle East, Canada, Latin America, and the Asia/Pacific.
Why Should Investors Buy ZTS After the Recent Fall? Just Go Here and Find Out
In the last trading session, Mylan Inc (NASDAQ:MYL) was up on high volume, trading at a volume of 5.71M versus its average daily volume of 4.04 million shares. At $40.25, the stock has attained market capitalization of 15.37 million. Mylan Inc. engages in the development, manufacture, marketing, licensing, and distribution of generic and branded generic pharmaceuticals, specialty pharmaceuticals, and active pharmaceutical ingredients (APIs) worldwide. It operates in two segments, Generics and Specialty.
Will MYL Continue To Move Higher? Find Out Here
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)